Nu Skin (NUS) has been battling persistent macroeconomic headwinds across most regions, which has affected customer and affiliate acquisition.
In a market like this, you should identify stocks most likely to underperform as a way of protecting your portfolio. Some stocks have had poor performances in the past years but then they have some very significant challenges that can take their value into a slump. Deep, top-line declines and restructuring deceleration have weighed down these same companies, and this usually consumes a lot of sales headwinds from various sectors. Realizing them early enough as an investor helps you make informed
Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.